Abstract
A substantial number of individuals have long-lasting adverse effects from a traumatic brain injury (TBI). Depression is one of these long-term complications that influences many aspects of life. Depression can limit the ability to return to work, and even worsen cognitive function and contribute to dementia. The mechanistic cause for the increased depression risk associated with a TBI remains to be defined. As TBI results in chronic neuroinflammation, and priming of glia to a secondary challenge, the inflammatory theory of depression provides a promising framework for investigating the cause of depression following a TBI. Increases in cytokines similar to those seen in depression in the general population are also increased following a TBI. Biomarker levels of cytokines peak within hours-to-days after the injury, yet pro-inflammatory cytokines may still be elevated above physiological levels months-to-years following TBI, which is the time frame in which post-TBI depression can persist. As tumor necrosis factor α and interleukin 1 can signal directly at the neuronal synapse, pathophysiological levels of these cytokines can detrimentally alter neuronal synaptic physiology. The purpose of this review is to outline the current evidence for the inflammatory hypothesis of depression specifically as it relates to depression following a TBI. Moreover, we will illustrate the potential synaptic mechanisms by which tumor necrosis factor α and interleukin 1 could contribute to depression. The association of inflammation with the development of depression is compelling; however, in the context of post-TBI depression, the role of inflammation is understudied. This review attempts to highlight the need to understand and treat the psychological complications of a TBI, potentially by neuroimmune modulation, as the neuropsychiatric disabilities can have a great impact on the rehabilitation from the injury, and overall quality of life.
| Original language | English |
|---|---|
| Pages (from-to) | 1693-1704 |
| Number of pages | 12 |
| Journal | Neural Regeneration Research |
| Volume | 13 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2018 |
Bibliographical note
Publisher Copyright:© 2018 Medknow Publications. All rights reserved.
Funding
Funding: CNB was supported in part by a Kentucky Spinal and Head Injury Trust trainee fellowship. Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (to ADB) and P30 GM110787 (to ADB). Author contributions: ADB conceived of the review, prepared literature review, and prepared the first draft of the manuscript. CNB and JMM participated in outlining the review and drafting the manuscript. All authors read, approved, and agreed to be accountable for all aspects of the final manuscript. Conflicts of interest: None declared. Financial support: CNB was supported in part by a Kentucky Spinal and Head Injury Trust trainee fellowship. Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (to ADB) and P30 GM110787 (to ADB).
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | R00 AG044445, P30 GM110787 |
| National Institutes of Health (NIH) | R00 AG044445, P30 GM110787 |
Keywords
- Astrocytes
- Chronic traumatic encephalopathy
- Concussion
- Inflammation
- Interleukin 1
- Major-depressive disorder
- Microglia
- N-methyl-D-aspartic acid
- Synaptic physiology
- Tumor necrosis factor a
ASJC Scopus subject areas
- Developmental Neuroscience